Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
We investigated hemodialysis membrane biocompatibility with respect to contact phase activation by determination of FXII-like activity (FXIIA) on the membrane surface and in the supernatant phase, during plasma contact with various hemodialysis membranes using an in vitro incubation test cell. The results were compared to the influence of these membranes on the activation of purified FXII. A time course for the generation of activated FXII using purified FXII solution at physiologic concentrations on two similar negatively charged polymers was performed. The membranes assessed were regenerated cellulose (Cuprophan; Akzo Faser AG, Germany), modified cellulosic (Hemophan; Akzo Faser AG), acrylonitrile-sodium methallyl copolymer-based membrane AN69S (Hospal, France), and SPAN, a new polyacrylonitrile-based copolymer (akzo Nobel AG). The plasma FXIIA at the membranes surface was significantly different between the membranes, while the supernatant phase FXIIA exhibited no significant differences. In contrast, activation of purified FXII in a plasma-free system with respect to supernatant activity indicated significant differences between the materials. A similar finding for the membrane-bound factor XIIA was also observed when purified factor XII was used. The membrane-bound FXIIA values observed in the plasma system containing heparin were significantly greater than in citrated plasma. This demonstrated the strong influence of heparin and the interaction of other plasma components to the membrane surface on the activation of contact phase of coagulation.
Matata
B M
BM
Bioengineering Unit, University of Strathclyde, Wolfson Centre, Glasgow, UK.
Courtney
J M
JM
Sundaram
S
S
Wark
S
S
Bowry
S K
SK
Vienken
J
J
Lowe
G D
GD
D000327:Adsorption; D001672:Biocompatible Materials; D002482:Cellulose / Q000031:analogs & derivatives; D005174:Factor XII / Q000737:chemistry / Q000378:metabolism*; D015956:Factor XIIa / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008567:Membranes, Artificial; D006435:Renal Dialysis / Q000295:instrumentation*; D013997:Time Factors
D001672:Biocompatible Materials; D008567:Membranes, Artificial; C054645:Hemophan; D005174:Factor XII; D002482:Cellulose; C009865:cuprammonium cellulose; D015956:Factor XIIa